Michael Y. Si

Michael Y. Si possesses extensive experience in biotechnology and biomedical engineering, with a significant focus on the development of antibody-drug conjugates (ADCs) for cancer treatment. Experience includes a role as a Graduate Research Assistant at the University of Alabama at Birmingham, where Michael worked on ADC and mAb-mediated drug delivery systems for triple-negative breast cancer. A position as a Bioprocess Engineer at The Ohio State University College of Engineering involved process development for mAb and ADC production. Earlier experience includes internships at BGI Genomics focusing on LC/MS method development and a role at Sanofi as a Senior Scientist, leading upstream activities and advancements in bioprocess development. Academic qualifications include a Bachelor of Science in Biotechnology from Qingdao University, a Bachelor of Science in Biotechnology from Missouri State University, a Master of Science in Biotechnology from the University of Alabama at Birmingham, and a Doctor of Philosophy in Biomedical Engineering from the same institution.